Page last updated: 2024-11-05

ici 204,219 and Sleep Wake Disorders

ici 204,219 has been researched along with Sleep Wake Disorders in 1 studies

zafirlukast: a leukotriene D4 receptor antagonist

Sleep Wake Disorders: Abnormal sleep-wake schedule or pattern associated with the CIRCADIAN RHYTHM which affect the length, timing, and/or rigidity of the sleep-wake cycle relative to the day-night cycle.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Suissa, S1
Dennis, R1
Ernst, P1
Sheehy, O1
Wood-Dauphinee, S1

Trials

1 trial available for ici 204,219 and Sleep Wake Disorders

ArticleYear
Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial.
    Annals of internal medicine, 1997, Feb-01, Volume: 126, Issue:3

    Topics: Absenteeism; Adult; Anti-Asthmatic Agents; Asthma; Female; Follow-Up Studies; Health Services; Human

1997